Boehringer Ingelheim and CDR-Life to develop Antibody Fragment-based Therapeutics for Geographic Atrophy Read more
Giving highest priority to ensure uninterrupted supply of medicines: Sharad Tyagi, Boehringer Ingelheim, India Read more
Domain Therapeutics achieves two discovery milestones in collaboration with Boehringer Ingelheim Read more
Lupin and Boehringer Ingelheim partner to develop and commercialise novel oncology drug to treat KRAS-driven cancers Read more